Summary
QDI Chart
Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology
SECAUCUS, N.J. , June 10, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced a collaboration with The University of Texas MD Anderson Cancer Center (MD Anderson) designed to improve the assessment of elevated risk of cancer in individuals who would benefit from medically appropriate cancer screenings.
What's Driving Quest Diagnostics Stock's 25.6% Rally in a Year?
DGX has shown notable strength in the past year, driven by robust core performance and contributions from acquisitions.
More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals
Quest's second "Know Your Health" survey explores Americans' perceptions and priorities on their well-being in 2025 Nearly one-third of Americans say their doctors/HCPs do not take the time to discuss preventive care and wellness with them; More than half of millennials, Gen Z cite barriers to accessing medical care SECAUCUS, N.J. , May 20, 2025 /PRNewswire/ -- questhealth.com, the consumer-initiated testing platform from Quest Diagnostics (NYSE: DGX), one of the nation's leading providers of diagnostic information services, today revealed the results of its second "Know Your Health" survey, conducted online by The Harris Poll among nearly 2,100 U.S. adults.
Quest Diagnostics Inc. (QDI) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has Quest Diagnostics Inc. ever had a stock split?
Quest Diagnostics Inc. Profile
| Medical - Diagnostics & Research Industry | Healthcare Sector | Mr. James E. Davis CEO | XFRA Exchange | US74834L1008 ISIN |
| US Country | 55,000 Employees | 7 Apr 2025 Last Dividend | 21 Jun 2005 Last Split | 17 Dec 1996 IPO Date |
Overview
Quest Diagnostics Incorporated, established in 1967 and based in Secaucus, New Jersey, is a prominent provider of diagnostic testing, information, and services both in the United States and internationally. The company operates with the mission to deliver critical diagnostic insights that lead to informed healthcare decisions. Using its extensive network of laboratories, patient service centers, and healthcare professionals, Quest Diagnostics offers a wide range of diagnostic information services. These services cater to a diverse clientele including physicians, hospitals, patients, health plans, government agencies, employers, and pharmaceutical companies. Through its flagship Quest Diagnostics brand and others such as AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum, the company aims to improve health outcomes by making better information available to the healthcare ecosystem.
Products and Services
- Diagnostic Information Services
- Risk Assessment Services for Life Insurance Industry
- Healthcare Information Technology Solutions
These encompass routine and non-routine clinical tests, advanced clinical testing, and anatomic pathology testing. Quest Diagnostics utilizes a vast array of technological platforms to provide critical diagnostic information that supports disease prevention, diagnosis, treatment, and management.
Quest Diagnostics provides comprehensive risk assessment services tailored to the needs of the life insurance sector. These services are designed to help insurance companies evaluate the health risks of policy applicants through a variety of diagnostic tests and assessments.
Offering cutting-edge information technology solutions, Quest Diagnostics helps healthcare organizations and clinicians enhance efficiency and patient care. These solutions encompass a wide range of IT services designed to facilitate the secure exchange of health information, improve lab ordering processes, and streamline patient record management.
Contact Information
